Articles
Lupus drug launch focuses on social media, advocacy orgs
November 5th, 2009 by Stephen Doogan
Human Genome Sciences and GlaxoSmithKline said online communication
will play a key role in the upcoming launch of lupus drug Benlysta. The
companies are considering various web channels, from advocacy groups to
social media.“Our launch approach will be very
patient-centric,” said Barry Labinger, EVP and chief commercial
officer, Human Genome. “We've got very strong clinical data in a
disease where there are no good alternatives, so I think there will be
a very high desire for patients who know about [Benlysta] to get it.”After
results this week showed Benlysta (belimumab) performed well in a
second Phase III clinical trial, executives from Human Genome said they
intend to file with FDA...
Two Teens with Lupus Win Spots in the Rose Parade with Kaiser Permanente
January 5th, 2009 by Stephen Doogan
Two southern California teens living with lupus will be among the riders aboard the Kaiser Permanente float in the 120th Annual Tournament of Roses Parade on January 1, 2009. Nathalie Gonzales and Jessica Southern will appear on the float with 12 other riders, ages 12 through 18, who are battling life-threatening diseases, including lupus, cancer, and sickle-cell anemia. Kaiser Permanente Health Plan physicians nominated the teens based on their positive attitudes and persevering spirits.With the theme, "Propel Your Dreams," the float design centers on Kaiser's ongoing health message, "Thrive." The float is a colorful and imaginative flying vehicle powered by...